Regenerative Medicine Solutions published a study of more than 72,000 people showing that those who received the latest shingles vaccine have a lower risk of stroke or heart failure compared to older versions.
Public source
Publisher name
Public post
Shingles vaccine may lower risk of stroke and heart failure? Besides reducing the risk of Herpes Zoster related disease (including of course shingles, but also trigemina…
Company
Regenerative Medicine Solutions
- Industry
- Hospitals
- Location
- Barcelona, ES
- Company size
- 2–10 employees
Latest activity
Latest activity from Regenerative Medicine Solutions
4 signals
Research & Knowledge
Regenerative Medicine Solutions published a study in Science by A. J. Wesolowski et al. (2026) showing that mouse tumors release the enzyme peroxiredoxin 1 (PRDX1) into the interstitial fluid to remove H2O2 near T cells, which weakens T cell receptor signaling.
Research & Knowledge
Regenerative Medicine Solutions did not claim any business signals about the author's company, but the post discusses a longitudinal single-cell RNA sequencing atlas assembled by Israeli and German researchers for Translational Skin Cancer Research and the German Cancer Consortium.
Research & Knowledge
Regenerative Medicine Solutions published a study by Freedland et al (2026) in the journal Cancer indicating that reaching a prostate-specific antigen level below 0.2 ng/mL is an indicator of improved patient survival in metastatic castration-sensitive prostate cancer patients.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
RegenHealth Physicians
RegenHealth Physicians reported on a patient case involving Luis, a 32-year-old diagnosed with multiple sclerosis in June 2024 who experienced pain shooting down his right arm and recurring numbness in his hand, which resolved after one infusion of regenerative medicine.
Research & Knowledge
Nature Portfolio
Nature Portfolio published a study in Nature Medicine comparing the live attenuated versus recombinant shingles vaccines and found that the recombinant vaccine was associated with a lower incidence of cardiovascular events across seven years of follow-up.
Research & Knowledge
Ribera Salud
Ribera Salud published an analysis of multiple randomized placebo-controlled trials confirming no major difference in cardiovascular events in heart failure patients.
Research & Knowledge
Connexall
Connexall published a first human trial showing that Experimental One-Dose Treatment cuts bad cholesterol by 52% in the first trial.
Research & Knowledge
CVS Health